Company Filing History:
Years Active: 2015
Title: Gabriele Annemarie Beer: Innovator in Cancer Diagnostics
Introduction
Gabriele Annemarie Beer is a notable inventor based in Penzberg, Germany. She has made significant contributions to the field of cancer diagnostics, particularly through her innovative work involving specific markers for cancer detection. Her dedication to improving diagnostic methods has the potential to enhance patient outcomes in oncology.
Latest Patents
Gabriele Annemarie Beer holds a patent for a method that focuses on the detection and diagnosis of cancer. This patent, titled "Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the MAGE-A3-marker," relates to MAGE-3 specific primers and probes. These tools are designed for use in new diagnostic kits and methods, which can aid in the immunotherapeutic treatment of specific populations of cancer patients suffering from MAGE-3 expressing tumors. She has 1 patent to her name.
Career Highlights
Gabriele is currently associated with GlaxoSmithKline Biologicals SA, where she continues to work on advancing cancer diagnostics. Her role in this prominent company allows her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Throughout her career, Gabriele has worked alongside notable colleagues such as Thierry Coche and Olivier Gruselle. These collaborations have further enriched her research and development efforts in cancer diagnostics.
Conclusion
Gabriele Annemarie Beer is a pioneering inventor whose work in cancer diagnostics is making a significant impact. Her innovative methods and dedication to improving patient care highlight the importance of research in the medical field.